English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18033/20233 (89%)
造訪人次 : 23240668      線上人數 : 272
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32324


    標題: Mechanisms of Lysophosphatidic Acid-Mediated Lymphangiogenesis in Prostate Cancer
    作者: Wu, Pei-Yi
    Lin, Yueh-Chien
    Huang, Yuan-Li
    Chen, Wei-Min
    Chen, Chien-Chin
    Lee, Hsinyu
    貢獻者: Acad Sinica, Inst Cellular & Organism Biol
    Natl Taiwan Univ, Dept Life Sci
    Asia Univ, Dept Biotechnol
    China Med Univ, China Med Univ Hosp, Dept Med Res
    Ditmanson Med Fdn Chia Yi Christian Hosp, Dept Pathol
    Chia Nan Univ Pharm & Sci, Dept Cosmet Sci
    Natl Taiwan Univ, Dept Elect Engn
    Natl Taiwan Univ, Inst Biomed Elect & Bioinformat
    Natl Taiwan Univ, Ctr Biotechnol
    關鍵字: LPA
    LPA receptor
    prostate cancer
    VEGF-C
    lymphangiogenesis
    日期: 2018-11
    上傳時間: 2019-12-16 09:35:42 (UTC+8)
    出版者: MDPI
    摘要: Prostate cancer (PCa) is the most common noncutaneous cancer in men worldwide. One of its major treatments is androgen deprivation therapy, but PCa frequently relapses as aggressive castration resistant local tumors and distal metastases. Hence, the development of novel agents or treatment modalities for advanced PCa is crucial. Many tumors, including PCa, first metastasize to regional lymph nodes via lymphatic vessels. Recent findings demonstrate that the bioactive lipid lysophosphatidic acid (LPA) promotes PCa progression by regulating vascular endothelial growth factor-C (VEGF-C), a critical mediator of tumor lymphangiogenesis and lymphatic metastasis. Many of the underlying molecular mechanisms of the LPA-VEGF-C axis have been described, revealing potential biomarkers and therapeutic targets that may aid in the diagnosis and treatment of advanced PCa. Herein, we review the literature that illustrates a functional role for LPA signaling in PCa progression. These discoveries may be especially applicable to anti-lymphangiogenic strategies for the prevention and therapy of metastatic PCa.
    關聯: Molecular Carcinogenesis, v.10, n.11, 413
    顯示於類別:[化妝品應用與管理系(所)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    cancers-10-00413.pdf563KbAdobe PDF283檢視/開啟
    index.html0KbHTML1002檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋